In the wider medical literature, there are well-recognised examples where potentially ‘deleterious’ variants or mutations can result in individual health benefit, including Sickle Cell Trait (for malaria resistance) [121] and HIV resistance for people with a 32 bp deletion in CCR5 [122], with further examples emerging [123]. The gene discussed is CCR5; the disease is malaria.